← FDA Drug Approvals (Drugs@FDA)
BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: PH HEALTH · Approved 2023-03-06
Drug application
- FDA Application #
ANDA205770- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- Generic name
- BISMUTH SUBCITRATE POTASSIUM, METRONIDAZOLE AND TETRACYCLINE HYDROCHLORIDE
- Active ingredients
- BISMUTH SUBCITRATE POTASSIUM; METRONIDAZOLE; TETRACYCLINE HYDROCHLORIDE
- Dosage form
- CAPSULE
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- PH HEALTH
- Manufacturer
- Par Health USA, LLC
- First approval
- 2023-03-06
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown